Stanford University
Showing 11-20 of 241 Results
-
Tina Baykaner
Assistant Professor of Medicine (Cardiovascular Medicine)
BioTina Baykaner is an Assistant Professor in the Department of Internal Medicine, Division of Cardiovascular Medicine and Electrophysiology. Following internal medicine residency, cardiovascular medicine and advanced heart failure fellowship trainings at University of California, San Diego and electrophysiology fellowship at Stanford University, Dr. Baykaner joined Stanford University faculty in 2018. She has published over 200 papers, book chapters and abstracts including over 100 original peer-reviewed articles, and delivered over 100 invited presentations in national and international meetings. She serves as associate editor, section editor and editorial board member of four electrophysiology journals and served in guideline writing committees.
Dr. Baykaner’s current research interests include outcomes research, epidemiology and mechanisms of rhythm disorders. She is currently funded by the National Institutes of Health to study patient related outcomes regarding atrial fibrillation (AF) ablation. She received prior research funding from American Heart Association and Heart Rhythm Society. Dr. Baykaner's clinical practice focuses on ablation of atrial and ventricular arrhythmias, SVTs, inappropriate sinus tachycardia management, device implantation and device extraction.
Dr. Baykaner is an active member of American Heart Association (AHA), American College of Cardiology (ACC), Heart Rhythm Society (HRS) and European Society of Cardiology (ESC). She serves as an elected member of the Digital Health Committee for HRS, and previously served as an elected member of the HRS Communications Committee and ACC Task Force ICD research committee. -
Rupan Bose, MD, MB
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioRupan Bose, MD, MB, is a Cardiologist and Clinical Assistant Professor in the Division of Cardiovascular Medicine at Stanford University. He specializes in Preventive Cardiology, with a particular focus on high-risk populations. His mission is to identify the underlying drivers of cardiovascular risk, and his clinic is focused on taking a data-driven approach to addressing each of those individual risk factors. He is also deeply involved in the intersection of medicine and technology, with a particular focus on leveraging emerging technologies and innovations to improve cardiovascular disease monitoring and outcomes.
Dr. Bose is a local Bay Area native. He completed his Medical Degree from the Keck School of Medicine of USC. He then completed his Residency in Internal Medicine at USC, followed by his Fellowship in Cardiovascular Medicine at Harbor-UCLA. With his interest in medicine and technology, he holds a Masters in Biotechnology (MB) with an emphasis on Bioinformatics from the University of Pennsylvania.
At Stanford, Dr. Bose serves in the Preventive Cardiology clinic and also the Stanford South Asian Translational Heart Initiative (SSATHI) clinic. He also serves as the Medical Director for the Inpatient Cardiology Services and the Medical Director of the Inpatient Cardiology (J7) Unit. Additionally, he serves on the Cardiology Consult service and Inpatient Cardiology service, where he supervises and teaches Fellows, Residents, and Medical Students from the Stanford University School of Medicine. -
Stephen Chang, MD, PhD
Instructor, Biochemistry
Instructor, Medicine - Cardiovascular MedicineBioPrior to a career in medicine, Dr. Chang was an English major and subsequent novelist at night. During the days, he taught literature part-time at Rutgers University, and for extra money, worked in a laboratory in NYC washing test tubes. Inspired by his laboratory mentor, he began volunteering at the hospital next door, and developed a love for interacting with patients. Through this experience, he saw how caring for others could form deep bonds between people - even strangers - and connect us in a way that brings grandeur to ordinary life.
In addition to seeing patients, Dr. Chang is a physician-scientist devoted to advancing the field of cardiovascular medicine. His research has been focused on identifying a new genetic organism that better models human heart disease than the mouse. For this purpose, he has been studying the mouse lemur, the smallest non-human primate, performing cardiovascular phenotyping (vital signs, ECG, echocardiogram) on lemurs both in-bred (in France) and in the wild (in Madagascar) to try to identify mutant cardiac traits that may be heritable - and in the process, characterize the first high-throughput primate model of human cardiac disease.
